<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for CTIC</title>
    <link />
    <description>Headlines for Cell Therapeutics, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Cell Therapeutics: Addicted to Reverse Stock Splits</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11899120/1/cell-therapeutics-addicted-to-reverse-stock-splits.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Thu, 18 Apr 2013 10:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Cell Therapeutics Enters $15M Loan Financing Agreement with Hercules Technology Growth Capital</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3453685/cell-therapeutics-enters-15m-loan-financing-agreement-with-hercules-technology-gr.aspx</link>
      <author>Benzinga</author>
      <pubDate>Thu, 28 Mar 2013 06:01:49 GMT</pubDate>
    </item>
    <item>
      <title>Vosaroxin: A Promising Drug For A Difficult Disease</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1293591-vosaroxin-a-promising-drug-for-a-difficult-disease.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 21 Mar 2013 16:29:44 GMT</pubDate>
    </item>
    <item>
      <title>Cell Therapeutics Management Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1236561-cell-therapeutics-management-discusses-q4-2012-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 28 Feb 2013 21:40:07 GMT</pubDate>
    </item>
    <item>
      <title>FDA Whiplashes This Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/21/fda-whiplashes-this-biotech/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 21 Feb 2013 14:42:00 GMT</pubDate>
    </item>
    <item>
      <title>2 Small-Cap Biotech Companies With Zero Debt And At Least $10 Million In Cash</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1150101-2-small-cap-biotech-companies-with-zero-debt-and-at-least-10-million-in-cash.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 01 Feb 2013 10:36:55 GMT</pubDate>
    </item>
    <item>
      <title>3 Small Cap Movers With Similar Trends But Different Outlooks</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1126461-3-small-cap-movers-with-similar-trends-but-different-outlooks.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 23 Jan 2013 04:25:41 GMT</pubDate>
    </item>
    <item>
      <title>The Soft Underbelly of ZIOPHARM Oncology</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/11/the-soft-underbelly-of-ziopharm-oncology/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 11 Jan 2013 21:38:00 GMT</pubDate>
    </item>
    <item>
      <title>Cell Therapeutics Opens Phase 3 Trial Enrollment for Pacritinib</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/09/cell-therapeutics-opens-phase-3-trial-enrollment/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 09 Jan 2013 14:33:00 GMT</pubDate>
    </item>
    <item>
      <title>Cell Therapeutics: Research On Tuesday's Run Raises More Questions Than Answers</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1102801-cell-therapeutics-research-on-tuesday-s-run-raises-more-questions-than-answers.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 09 Jan 2013 12:18:58 GMT</pubDate>
    </item>
    <item>
      <title>JPMorgan Healthcare Conference Highlights: Incyte</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/08/jpmorgan-healthcare-conference-highlights-incyte/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 08 Jan 2013 10:14:00 GMT</pubDate>
    </item>
    <item>
      <title>CTIC: Strong 'Sell' Therapeutics?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1070571-ctic-strong-sell-therapeutics.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 18 Dec 2012 10:34:26 GMT</pubDate>
    </item>
    <item>
      <title>2 Highly Speculative Biotech Stocks Worth A Look In The Wake Of Recent Developments</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1069911-2-highly-speculative-biotech-stocks-worth-a-look-in-the-wake-of-recent-developments.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 18 Dec 2012 03:29:21 GMT</pubDate>
    </item>
    <item>
      <title>A Case of Vertigo From Vertex Pharmaceuticals?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/12/14/a-case-of-vertigo-from-vertex-pharmaceuticals/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 14 Dec 2012 09:56:00 GMT</pubDate>
    </item>
    <item>
      <title>Is Telik A Good Buy After Increasing 24% In One Day?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1060901-is-telik-a-good-buy-after-increasing-24-in-one-day.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 12 Dec 2012 16:16:37 GMT</pubDate>
    </item>
    <item>
      <title>Gilead Needs to Ask, "YMI Buying This Biotech?"</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/12/12/gilead-needs-to-ask-ymi-buying-this-biotech/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 12 Dec 2012 15:10:00 GMT</pubDate>
    </item>
    <item>
      <title>Ballots Are In: Worst CEO in the Biotech Industry Is . . .</title>
      <link>http://www.fool.com/news/xt/ycharts/ycharts.com/analysis/story/ballots_are_in_worst_ceo_in_the_biotech_industry_is___.aspx</link>
      <author>YCharts</author>
      <pubDate>Fri, 07 Dec 2012 10:49:31 GMT</pubDate>
    </item>
    <item>
      <title>The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/12/07/the-worst-performing-biotechs-in-2012-and-1-to-avo/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 07 Dec 2012 10:17:00 GMT</pubDate>
    </item>
    <item>
      <title>The Worst Biotech CEO of 2012 Is...</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11786505/1/the-worst-biotech-ceo-of-2012-is.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 07 Dec 2012 09:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Your Vote Counts: Who Is the Worst Biotech CEO of 2012?</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11782309/1/your-vote-counts-who-is-the-worst-biotech-ceo-of-2012.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Tue, 04 Dec 2012 08:30:00 GMT</pubDate>
    </item>
  </channel>
</rss>
